Bethesda, MD, United States of America

Moshe Shmuklarsky

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Moshe Shmuklarsky

Introduction

Moshe Shmuklarsky is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of medicine, particularly in the prevention of malaria. With a total of 3 patents to his name, his work has the potential to impact public health positively.

Latest Patents

Shmuklarsky's latest patents focus on regimens of tafenoquine for the prevention of malaria in malaria-naïve subjects. The methods he developed involve administering a compound of Formula (I) to G6PD-normal human subjects. This compound can be given before, during, or after potential exposure to malaria. His patents also include the creation of kits that contain specific doses of Formula (I) along with instructions for administration. These methods aim to meet regulatory requirements for efficacy in preventing malaria, showcasing his innovative approach to tackling this global health issue.

Career Highlights

Throughout his career, Shmuklarsky has worked with various organizations, including 60 Degrees Pharmaceuticals, LLC and the US Government as represented by the Secretary of the Army. His experience in these roles has contributed to his expertise in developing effective malaria prevention strategies.

Collaborations

Some of his notable coworkers include Bryan L. Smith and John P. Jones. Their collaboration has likely enhanced the research and development of his innovative solutions.

Conclusion

Moshe Shmuklarsky's contributions to malaria prevention through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…